Surrogacy Market Size Projected to Reach $100.38 billion by 2034 | 13.43%

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

According to Straits Research, the global surrogacy market size was valued at $24.53 billion in 2025 and is projected to grow from $29.78 billion in 2026 to $140.35 billion by 2034, at a CAGR of 21.39% during the forecast period 2026–2034.

Straits Research, a leading market research organization, announced the release of the report titled “Surrogacy Market Size and Outlook Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

The surrogacy market is segmented based on type, technology, age group, and region. Some of the insights provided in the report are highlighted below:

• The 35-37 years segment is expected to register a CAGR of 20.5% during the forecast period.
• North America is expected to lead the market during the forecast period, owing to advanced medical infrastructure and high IVF success rates.
• Clinics are integrating genetic screening into IVF-surrogacy workflows to identify chromosomal or inherited abnormalities early.
• Germany is expected to lead the Europe surrogacy market favored by the presence of specialized fertility centersand insurance coverage for fertility treatments in certain cases.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Regional Analysis

North America is the largest shareholder in the global surrogacy market and is expected to grow at a CAGR of 6.3% during the forecast period. The region's dominance is primarily attributed to the well-established fertility treatment infrastructure, high adoption of assisted reproductive technologies (ART), and favorable surrogacy regulations in several U.S. states. The United States continues to account for the majority of the regional market due to the availability of specialized fertility clinics, advanced IVF procedures, and a supportive legal framework that varies by state, allowing intended parents greater flexibility. Additionally, Mexico has emerged as a promising destination for cross-border surrogacy owing to its comparatively affordable medical services and growing fertility care ecosystem.

Europe is anticipated to expand at a CAGR of 6.1% during the forecast period. Market growth is driven by the increasing prevalence of infertility, rising acceptance of assisted reproductive technologies, and supportive IVF policies across several European countries. According to the European Society of Human Reproduction and Embryology (ESHRE), more than 25 million people in the European Union are affected by infertility, contributing to the growing demand for fertility treatments, including surrogacy. While surrogacy regulations vary significantly across the region with altruistic surrogacy permitted in countries such as the United Kingdom and commercial surrogacy prohibited in several others including Germany, France, Italy, and Spain the continued expansion of fertility services and medical tourism is expected to support market growth throughout the forecast period.

Market Segments

The contents of the report are as follows:

By Type

• Gestational Surrogacy
• Traditional Surrogacy

By Technology

• IVF with ICSI
• IVF without ICSI
• Intrauterine Insemination

By Age Group

• Below 35 Years
• 35-37 Years
• 38-39 Years
• 40-42 Years
• 43-44 Years
• Over 44 Years

By Region

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa